Skip to main content
SpringerLink
Log in

Zwei ethische Grundvoraussetzungen psychiatrischer Forschung

  • Conference paper
Positionen der Psychiatrie

  • 2256 Accesses

Zusammenfassung

Sorgfältige Risiko-Nutzen-Bewertung und gültige Einwilligung nach Aufklärung dienen dem Wohl des Patienten, dem Schutz bzw. der Schadensvermeidung und der Achtung der Selbstbestimmung des Patienten. Dies wird mit Studien zur Früherfassung und -intervention von Vor- und Frühstadien psychischer Krankheit und placebokontrollierten Prüfungen, mit der therapeutischen Fehlwahrnehmung bei Prüfungen und dem Umgang mit Zufallsbefunden bei Reihenuntersuchungen exemplifiziert. Empfohlen werden eine 3-stufige Validierung der Risiko-Nutzen-Bewertung und ein Verständnis der Aufklärung des Patienten nicht nur als dessen Entscheidungsgrundlage, sondern auch als vertrauensfördernde Maßnahme.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 9.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Appelbaum PS, Roth LH, Lidz CW (1982) The therapeutic misconception: Informed consent in psychiatric research. Internat J Law Psychiatry 5:319–329

    Article  CAS  Google Scholar 

  • Appelbaum PS, Lidz CW (2008) Re-evaluating the therapeutic misconception: response to Miller and Joffe. Kennedy Inst Ethics J 16:367–373

    Article  Google Scholar 

  • Baldwin D, Broich K, Fritze J, Kasper S, Westenberg H, Möller HJ (2003) Placebo-controlled studies in depression: necessary, ethical and feasible. Eur Arch Psychiatry Clin Neurosci 253:22–28

    Article  PubMed  Google Scholar 

  • Benkert O, Maier W (1990) The Necessity of Placebo Application in Psychotropic Drug Trials. Pharmacopsychiat 23:203–205

    Article  CAS  Google Scholar 

  • Carpenter WT Jr, Appelbaum PS, Levine RJ (2003) The Declaration of Helsinki and Clinical Trials: A Focus on Placebo- Controlled Trials in Schizophrenia. Am J Psychiatry 160:356–362

    Article  PubMed  Google Scholar 

  • Corcoran C, Malaspina D, Hercher L (2005) Prodromal interventions for schizophrenia vulnerability: the risks of being »at risk«. Schizophrenia Research 73:173–184

    Article  PubMed  Google Scholar 

  • Conus P, Ward J, Lucas N, Cotton S, Yung AR, McGorry PD (2010) Characterisation of the prodrome to a first episode of psychotic mania: Results of a retrospective study. J Affect Disorders 124:341–345

    Article  PubMed  Google Scholar 

  • Cornblatt BA, Lencz T, Kane JM (2001) Treatment of the schizophrenia prodrome: is it presently ethical? Schizophr Res 51:31–38

    Article  PubMed  CAS  Google Scholar 

  • Emanuel EJ, Miller FG (2001) The Ethics of Placebo-Controlled Trials – A Middle Ground. N Engl J Med 345:915–919

    Article  PubMed  CAS  Google Scholar 

  • EMEA (2002) Note for Guidance on Clinical Investigation of Medicinal Products in the Treatment of Depression. www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003526.pdf. Zugegriffen: 3. September 2011

  • Fournier JC, DeRubeis RJ, Hollon SD, Dimidjian S, Amsterdam JD, Shelton RC, Fawcett J (2010) Antidepressant Drug Effects and Depression Severity: A Patient-Level Metaanalysis. JAMA 303:47–53

    Article  PubMed  CAS  Google Scholar 

  • Garattini S, Bertelé V (2007) Non-inferiority trials are uethical because they disregard patients' interests. Lancet 370:1875–1877

    Article  PubMed  Google Scholar 

  • Garattini S, Bertele V, Bassi LL (2003) How can research ethics committees protect patients better? BMJ 326:1199–1201

    Article  PubMed  Google Scholar 

  • Häfner H, Maurer K (2006) Early detection of schizophrenia: current evidence and future perspectives. World Psychiatry 5:130–138

    PubMed  Google Scholar 

  • Helmchen H (2005) Ethische Implikationen placebokontrollierter Prüfungen von Psychopharmaka. Nervenarzt 76:1319–1329

    Article  PubMed  CAS  Google Scholar 

  • Illes J (2010) Empowering brain science with neuroethics. The Lancet 376:1294–1295

    Article  Google Scholar 

  • Illes J, Borgelt E (2009) Brain imaging: Incidental findings: in practice and in person. Nat Rev Neurol 5:643–644

    Article  PubMed  Google Scholar 

  • Illes J, Chin VN (2008) Bridging Philosophical and Practical Implications of Incidental Findings in Brain Research. J Law Med Ethics 36:298–304

    Article  PubMed  Google Scholar 

  • Illes J, Kirschen MP, Edwards E, Bandettini P, Cho MK, Ford PJ, Glover GH, Kulynych J, Macklin R, Michael DB, Wolf SM, Grabowski T, Seto B (2008) Practical approaches to incidental findings in brain imaging research. Neurology 70:384–390

    Article  PubMed  CAS  Google Scholar 

  • Kimmelman J (2007) The therapeutic misconception at 25: treatment, research, and confusion. Hastings Cent Rep 37:36–42

    Article  PubMed  Google Scholar 

  • Klosterkoetter J, Schultze-Lutter F (2010) Prevention and early treatment. In: Helmchen H, Sartorius N (Hrsg) Ethics in Psychiatry. Springer, Dordrecht, S 235–262

    Chapter  Google Scholar 

  • Lancet Editorial (2009) Teaching responsible conduct of research. Lancet 374:1568

    Google Scholar 

  • Lidz CW, Appelbaum PS, Grisso T, Renaud M (2004) Therapeutic misconception and the appreciation of risks in clinical trials. Internat J Law Psychiatry 58:1689–1697

    Google Scholar 

  • Maclean A (2009) Autonomy, Informed Consent and Medical Law. Cambridge University Press, New York

    Book  Google Scholar 

  • Miller FG, Joffe S (2006) Evaluating the therapeutic misconception. Kennedy Inst Ethics J 16:353–366

    Article  PubMed  Google Scholar 

  • Morris Z (2009) Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 339:b3016

    Article  PubMed  Google Scholar 

  • Propping P (2010) Genetics – Ethical Implications of Research, Diagnostics and Counseling. In: Helmchen H, Sartorius N (Hrsg) Ethics in Psychiatry. Springer, Dordrecht,S 459–486

    Chapter  Google Scholar 

  • Shaw RL, Senior C, Peel E, Cooke R, Donnelly LS (2008) Ethical Issues in Neuroimaging Health Research. J Health Psychol 13:1051–1059

    Article  PubMed  Google Scholar 

  • Went L (1990) Ethical issues policy statement on Huntington's disease molecular genetics predictive test. International Huntington Association. World Federation of Neurology. J Med Genetics 27:34–38

    Article  CAS  Google Scholar 

  • Wong C, Davidson L, Anglin D, Link B, Gerson R, Malaspina D, McGlashan T, Corcoran C (2009) Stigma in families of individuals in early stages of psychotic illness: family stigma and early psychosis. Early Intervention in Psychiatry 3:108–115

    Article  PubMed  Google Scholar 

  • Yung AR, Nelson B, Stanford C, Simmons MB, Cosgrave EM, Killackey E, Phillips LJ, Bechdolf A, Buckby J, McGorry PD (2008) Validation of «prodromal” criteria to detect individuals at ultra high risk of psychosis: 2-year follow-up. Schizophr Res 105(1–3):10–7

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Psychiatrie und Psychotherapie, Charité - Universitätsmedizin Berlin, Eschenallee 3, 14050, Berlin

    Prof. em. Dr. med. Hanfried Helmchen

Authors
  1. Prof. em. Dr. med. Hanfried Helmchen
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik für Psychiatrie, Psychotherapie und Psychosomatik, Universitätsklinikum Aachen, Pauwelsstraße 30, 52074, Aachen

    Frank Schneider

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Helmchen, H. (2012). Zwei ethische Grundvoraussetzungen psychiatrischer Forschung. In: Schneider, F. (eds) Positionen der Psychiatrie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-25476-5_42

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-25476-5_42

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-25475-8

  • Online ISBN: 978-3-642-25476-5

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation